The ATAC Research Fund and Kirsten's Legacy is located at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona. TGen is currently leading the most comprehensive Genomics adrenal cancer study to date and the ATAC Research project is now one of the leaders in adrenal cancer research worldwide. TGen is one of the few facilities in the world that houses such a vast array of technologies and to this date has the largest biomedical super computer anywhere. Many of these technologies have never before used on ACC research and in some cases never used on any other cancer research. TGen has and will continue to discover groundbreaking technologies and hopeful new targets, producing more Adrenocortical Carcinoma (ACC) data than ever before.
THANK YOU FOR YOUR SUPPORT
A Phase I, open-label, non-randomized, dose-finding trial conducted at multiple clinical centers. The study is designed to determine the safety, tolerability and PK of TKM-080301 in adult patients with solid tumors or lymphomas that are refractory to standard therapy or for whom there is no standard therapy.
If you're interested please contact the following person: